Infliximab in inflammatory bowel disease

Anti-tumor necrosis factor (TNF) therapy has revolutionized the medical treatment of the inflammatory bowel diseases (IBD), Crohn’s disease (CD), and ulcerative colitis. Twenty years ago, infliximab became the first anti-TNF agent approved for IBD. Data from randomized controlled trials, large obser...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ther Adv Chronic Dis
Asıl Yazarlar: Papamichael, Konstantinos, Lin, Steve, Moore, Matthew, Papaioannou, Garyfallia, Sattler, Lindsey, Cheifetz, Adam S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2019
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6435871/
https://ncbi.nlm.nih.gov/pubmed/30937157
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622319838443
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller